By the end of the session participants should be able to: Understand dysbiosis and gut wellness Identify tips to manage abdominal pain Understand the role of diet in immunologic modulation Understand the use of probiotics for gut wellness Moderator: - Bidhata Khatri, FIP Health and Medicines Information Section (HaMIS) Secretary FIP, India Panelists: - Saman Khalesi, Senior Lecturer and Discipline Lead Nutrition Central Queensland University (CQUniversity)
MASH : Survodutide has the most advanced MASH program with Breakthrough Therapy Designation and dedicated Phase 3 trials
Some people may not be able to reach or tolerate the target dose due to side effects
"Tirzepatide versus Insulin Glargine in Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4): A Randomised, Open-Label, Parallel-Group, Multicentre, Phase 3 Trial." The Lancet, 2021, 398(10313), 1811-1824
Sources: NIAAA Women and Alcohol (2022)